Kardis Phillip John II 4

What Happened

• Phillip John Kardis II, President, CEO and a director of Chimera Investment Corporation (CIM), was granted 194,774 restricted stock units (RSUs) on 2026-01-20. The Form 4 lists the acquisition price as $0.00 (award/grant), so the transaction is an equity compensation award rather than an open‑market purchase or sale.

Key Details

• Transaction date: 2026-01-20; Form 4 filed: 2026-01-21 (timely).
• Transaction type/code: Award/Grant (A).
• Quantity and price: 194,774 RSUs @ $0.00; reported acquisition value $0 on the Form 4.
• Vesting/settlement: RSUs vest one‑third per year on Dec 31 of 2026, 2027 and 2028 and will be settled 100% in Chimera common stock (see footnote).
• Economic terms: Each RSU (and dividend equivalent right included) is the economic equivalent of one share of Chimera common stock.
• Shares owned after transaction: Not specified in the excerpt provided.
• Filing timeliness: Filed the day after the award date (appears timely).

Context

• RSU grants are a standard form of executive compensation and are not the same as an open‑market purchase (so they are less a direct signal of immediate insider bullishness). These RSUs include dividend‑equivalent rights and will convert to actual shares as they vest per the stated schedule. The reporting person notes they do not intend to separately report vesting or delivery of the shares.